BiondVax Pharmaceuticals Ltd. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (84)

Latest Posts

About This Stock More About This Stock
Executive Interview With Josh Phillipson Of Biondvax Pharmaceuticals
Video By: Edison
Tuesday, December 17, 2019 8:39 PM EDT
BiondVax's Josh Phillipson spoke with Edison TV about the company's M-001 Universal Flu Vaccine pivotal Phase 3 clinical trial.
In this video: BVXV
Watch
BiondVax Receives €8m From The European Investment Bank
Article By: TalkMarkets Newswire
Tuesday, October 23, 2018 1:54 AM EDT
The money from the EIB is in support of manufacturing facility and ongoing Phase 3 clinical trial.
In this article: BVXV
Read
BiondVax Appoints CRO To Conduct Pivotal Clinical Efficacy Phase 3 Trial Of Its Novel Universal Flu Vaccine Candidate
Article By: PR Newswire
Tuesday, March 13, 2018 9:27 AM EDT
BiondVax Pharmaceuticals developer of the Universal Flu Vaccine candidate M-001, announced today the signing of a Master Service Agreement with a contract research organization to conduct the first pivotal, clinical efficacy, Phase 3 trial of M-001.
In this article: BVXV
Read
BiondVax And European UNISEC Consortium To Host Universal Flu Vaccine Conference
Article By: PR Newswire
Thursday, February 8, 2018 10:40 AM EDT
BiondVax Pharmaceuticals Ltd. developer of a Universal Flu Vaccine candidate currently in preparation for a Phase 3 clinical trial, and the European UNISEC consortium announced today they will co-host the Annual UNISEC Consortium Meeting.
In this article: BVXV
Read
BiondVax Universal Flu Vaccine Patent Granted In India
Article By: PR Newswire
Tuesday, January 2, 2018 10:05 AM EDT
With a population of over 1.3 billion people, and high population density in some of the major cities, India is an important potential market for BiondVax and a universal flu vaccine may significantly improve public health.
In this article: BVXV
Read

Latest Tweets for $BVXV

No tweets yet!

PARTNER HEADLINES

$BVXV

Global Markets, Global News
Ayelet Wolf 6/25/2019 12:02:27 AM

What's your latest take on $TEVA? Also do you have an opinion on $BVXV?

BiondVax and European UNISEC Consortium to Host Universal Flu Vaccine Conference
Susan Miller 2/8/2018 3:45:14 PM

Looks good. I recently started following $BVXV

BiondVax Universal Flu Vaccine Patent Granted in India
Harry Goldstein 1/2/2018 3:16:11 PM

Promising news. What other countries has a patent been awarded in? $BVXV

1 to 4 of 4 comments